DrugPatentWatch Database PreviewSee Plans and Pricing
« Back to Dashboard
GW842166 is an investigational drug.
There have been 6 clinical trials for GW842166. The most recent clinical trial was a Phase 2 trial, which was initiated on July 1st 2007.
The most common disease conditions in clinical trials are Osteoarthritis, Inflammation, and Osteoarthritis, Knee. The leading clinical trial sponsors are GlaxoSmithKline and [disabled in preview].
Recent Clinical Trials for GW842166
|Dose Response and Efficacy of GW842166 in Pain||GlaxoSmithKline||Phase 1|
|Relative Bioavailability Study on a Single Dose of GW842166X in Healthy Male and Female Subjects.||GlaxoSmithKline||Phase 1|
|A Study Of The Effects Of CB2 Compound Of GW842166 In Patients With Osteoarthritis||GlaxoSmithKline||Phase 2|